IP Library › Granted Patent US 12,275,997
Granted Patent B2
US 12,275,997 · App. 17/976,128 · Granted Apr 15, 2025

System and method for determining copies-per-unit-volume using PCR and flow control of droplets

Inventors: Gordon A. Janaway (Castro Valley, CA); Mark Andersen (Carlsbad, CA); Kornelija Zgonc (Carlsbad, CA); Michael C. Pallas (San Bruno, CA); Marcin Sikora (Burlingame, CA); Casey R. Mcfarland (San Francisco, CA); Ferrier N. Le (San Jose, CA); Haopeng Wang (Arlington, VA); Jian Gong (San Marcos, CA); Gothami Padmabandu (San Diego, CA)
Assignee: Life Technologies Corporation
C12Q1/6886C12Q1/686G01N21/6486C12Q2600/158C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,275,997
App. No.
17/976,128
Granted
Apr 15, 2025
Kind
B2
Abstract

Methods and systems for quantification of a target nucleic acid in a sample are provided. The method includes forming a plurality of discrete sample portions. Each of the plurality of discrete sample portions comprising a portion of the sample, and a reaction mixture. The method further includes amplifying the plurality of discrete sample portions to form a plurality of discrete processed sample portions. At least one discrete processed sample portion containing nucleic acid amplification reaction products. Fluorescence signals are detected from the at least one of the plurality of discrete processed sample portions to determine a presence of the at least one target nucleic acid. The method also includes determining the respective volumes of the plurality of the plurality of discrete processed sample portions, and estimating the number of copies-per-unit-volume of the at least one target nucleic acid in the sample. Estimating the number of copies-per-unit-volume is based on the number of discrete processed sample portions determined to contain the at least one target nucleic acid therein.

Claims (31)

1. A system, comprising:

a droplet apparatus, in a first configuration, capable of forming a plurality of discrete sample portions of a sample comprising a target nucleic acid, each of the plurality of discrete sample portions comprising a portion of the sample, a reference dye, and a reaction mixture, wherein the plurality of discrete sample portions comprises discrete sample portions of a plurality of sizes;

an amplification apparatus configured to amplify the plurality of discrete sample portions to form at least one discrete processed sample portion containing nucleic acid amplification reaction product of the target nucleic acid;

a detection apparatus configured to:

detect a fluorescence signal from the at least one of the plurality of discrete processed sample portions in response to a presence of the at least one target nucleic acid and a light scattering property, and

detect a real-time fluorescence signal from the at least one of the plurality of discrete sample portions to determine a Cq value;

an optical imager configured to produce an image of the plurality of discrete processed sample portions; and

a processor configured to:

determine the respective volumes of the plurality of discrete processed sample portions, from the image, by measuring an optical property of each discrete processed sample portion to determine a dimension of each discrete processed sample portion, and

determine an amount of the target nucleic acid based on the number of discrete processed sample portions containing the target nucleic acid therein, and the Cq value.

2. The system of claim 1 , wherein the processor is further configured to determine the respective volumes of the plurality of discrete processed sample portions by analyzing a time-of-flight of the processed sample portions.

3. The system of claim 1 , further comprising a processor configured to estimate a portion size of the discrete sample portions to provide a predetermined average number of copies a target nucleic acid within the discrete sample portions.

4. The system of claim 1 , wherein the droplet apparatus is configured to form the plurality of discrete sample portions of at least one of a plurality of sizes, substantially two different sizes, or substantially a plurality of predetermined sizes.

5. The system of claim 1 , wherein the droplet apparatus, in the first configuration, is further capable of forming each of the plurality of discrete sample portions so that it is at least partially surrounded by a medium that is at least substantially immiscible with the plurality of discrete sample portions.

6. The system of claim 5 , wherein the medium that is substantially immiscible with the plurality of sample portions comprises at least one of a mineral oil, a silicone oil, a paraffin oil, a fluorinated fluid, or a perfluorinated polyether.

7. The system of claim 1 , wherein the droplet apparatus, in the first configuration, is further capable of forming the plurality of discrete sample portions to comprise at least one selected from the group consisting of: a porous bead and a magnetic bead.

8. The system of claim 1 , further comprising a processor configured to estimate the number of copies-per-unit-volume of the target nucleic acid in the sample based on the number of discrete processed sample portions determined to contain the at least one target nucleic acid therein.

9. The system of claim 1 , wherein the processor is further configured to determine the dimension of each discrete processed sample portion using at least one of the following group: a passive reference dye, optical refraction properties, optical imaging for measurement, optical reflection properties, optical absorbance properties, optical transmission properties, and a ladder of standard droplet sizes using different reference dyes.

10. The system of claim 1 , wherein the processor is further configured to determine the amount of the target nucleic acid based on the determined volumes of the plurality of discrete processed sample portions.

11. The system of claim 1 , wherein the processor is further configured to determine a size of discrete processed sample portion which provides a target percentage of discrete processed sample portions that test positive to determine the amount of the target nucleic acid.

12. A method, comprising:

forming a plurality of discrete sample portions of a sample comprising a target nucleic acid, each of the plurality of discrete sample portions comprising a portion of the sample, wherein the plurality of discrete sample portions comprises discrete sample portions of a plurality of sizes;

amplifying the plurality of discrete sample portions to form at least one discrete processed sample portion containing a nucleic acid amplification reaction product of the target nucleic acid;

detecting a fluorescence signal from the at least one of the plurality of discrete processed sample portions;

detecting a real-time fluorescence signal from the at least one of the plurality of discrete sample portions to determine a Cq value;

using an optical imager, determining the respective volumes of the plurality of the plurality of discrete processed sample portions by imaging the plurality of discrete processed sample portions;

determining a dimension of each of the discrete sample portions to determine a volume by measuring an optical property of each discrete sample portion; and

determining an amount of the target nucleic acid based on the number of discrete processed sample portions containing the target nucleic acid therein, and a Cq value.

13. The method of claim 12 , wherein the method further comprises determining the dimension of each discrete processed sample portion using at least one of the following group: a passive reference dye, optical refraction properties, optical imaging for measurement, optical reflection properties, optical absorbance properties, optical transmission properties, and a ladder of standard droplet sizes using different reference dyes.

14. The method of claim 12 , wherein determining the amount of the target nucleic acid is further based on the determined volumes of the plurality of discrete processed sample portions.

15. The method of claim 12 , further comprising determining a size of discrete processed sample portion which provides a target percentage of discrete processed sample portions that test positive to determine the amount of the target nucleic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: JANAWAY, GORDON; ANDERSEN, MARK; ZGONC, KORNELIJA; PALLAS, MICHAEL; SIKORA, MARCIN; MCFARLAND, CASEY; LE, FERRIER; WANG, HAOPENG; GONG, JIAN; PADMABANDU, GOTHAMI
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 070261/0278 →
Continuity (6)
Continuation 16741299 · Jan 13, 2020
Continuation 15080801 · Mar 25, 2016
Continuation 14009304
Provisional Application 61481085 · Apr 29, 2011
Provisional Application 61470713 · Apr 1, 2011
Related Publication 20230122742A1 · Apr 20, 2023
References Cited (16)
US 9322055B2 · Janaway · 2016 [cited by examiner]
US 10557174B2 · Janaway · 2020 [cited by examiner]
US 20040002169A1 · Kraus et al. · 2004 [cited by applicant]
US 20050042639A1 · Knapp et al. · 2005 [cited by applicant]
US 20140087386A1 · Chiu · 2014 [cited by examiner]
WO WO9847003A1 · 1998 [cited by applicant]
WO WO2007024798A2 · 2007 [cited by applicant]
WO WO2007149432A2 · 2007 [cited by applicant]
WO WO2010117461A2 · 2010 [cited by applicant]
Beer N. R., et al., “On-Chip, Real-Time, Single-Copy Polymerase Chain Reaction in Picoliter Droplets,” Analytical Chemistry, Nov. 15, 2007, vol. 79, No. 22, pp. 8471-8475. [cited by applicant]
Curcio M., et al., “Continuous segmented-Flow Polymerase Chain Reaction for HighThroughput Miniaturized DNA Amplification,” Analytical Chemistry, vol. 75, No. 1, pp. 1-7. (2003). [cited by applicant]
Dorfman K.D., et al., “Contamination-Free Continuous Flow Microfluidic Polymerase Chain Reaction for Quantitative and Clinical Applications,” Analytical Chemistry, Jun. 1, 2005, vol. 77, No. 11, pp. 3700-3704. [cited by applicant]
Dressman D., et al., “Transforming Single DNA Molecules Into Fluorescent Magnetic Particles for Detection and Enumeration of Genetic Variations,” Proceedings of the National Academy of Sciences of the United States of A… [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2012/031533 mailed Jun. 12, 2012, 12 pages. [cited by applicant]
Kojima T., et al., “PCR Amplification from Single DNA Molecules on Magnetic Beads in Emulsion: Application for High-Throughput Screening of Transcription Factor Targets,” Nucleic Acids Research, 2005, vol. 33 (17), 9 Pa… [cited by applicant]
PCT/US2012/031533, International Preliminary Report on Patentability, Oct. 1, 2013, 6 pages. [cited by applicant]